Top Stories

Retail giant Walmart Inc. (WMT) has deepened its strategic partnership with Microsoft Corp. (MSFT) by choosing the technology giant as its preferred as well as strategic cloud provider and tap into the full range of Microsoft's cloud solutions. The...

Australia will on Wednesday release June results for the leading economic index from Westpac, highlighting a light day for Asia-Pacific economic activity. In May, the index dipped 0.22 percent. Malaysia will see June numbers for consumer prices; in...


Facing widespread criticism for his performance during a press conference with Russian Vladimir Putin, President Donald Trump claims he misspoke when he appeared to question why Russia would be interested in interfering in the 2016 president election. Trump...


Stocks moved mostly higher over the course of the trading day on Tuesday after recovering from an initial move to the upside. With the gains on the day, the Nasdaq set a new record closing high and the S&P 500 reached its best closing level in well over...


American legendary boxer Floyd Mayweather is the world's highest-paid entertainer, according to Forbes magazine. He earned $285 million in pretax earnings across a 12-month period beginning 1 June 2017, almost entirely on the strength of his August...

pharma-gainers-071018.jpg The following are some of today's top gainers in the pharma/biotech sector.
asian-markets2_10jul18.jpg Asian stock markets are in negative territory on Wednesday and U.S. stock futures declined, while the safe-haven strengthened amid escalating trade tensions between the world's two largest economies after the U.S. said it is considering imposing 10 percent tariffs on an additional $200 billion worth of Chinese imports. Crude oil prices slipped in Asian trades after rising overnight.
pharma-daily-071018.jpg Today's Daily Dose brings you news about SCYNEXIS' Dove study results; termination of the merger agreement between Idera and BioCryst Pharma; withdrawal of Advaxis' Conditional Marketing Authorization Application in the European Union for Axalimogene filolisbac and stock offering of ArQule.
markets-111714_11jul18.jpg European stocks may succumb to selling pressure on Wednesday after the United States announced it would slap 10 percent tariffs on an extra 200 billion worth of Chinese imports in an escalating trade conflict between the world's two biggest economies. Investors...
Read More
trump4-071718.jpg Facing widespread criticism for his performance during a press conference with Russian Vladimir Putin, President Donald Trump claims he misspoke when he appeared to question why Russia would be interested in interfering in the 2016 president election.
Read More
paulryan-071718.jpg House Speaker Paul Ryan, R-Wis., indicated Tuesday he is willing to consider additional sanctions on Russia after twelve Russian intelligence officers were indicted for crimes intended to interfere with the 2016 presidential election.
Read More
Goldman Sachs Group, Inc. on Tuesday reported a 44 percent surge in profit for the second quarter from last year, reflecting higher revenues across all segments. The company noted that revenues were the highest second-quarter revenue in nine years. Both revenue and earnings per share for the quarter beat analysts' expectations. The company's shares are down 0.4 percent in pre-market activity.
Read More
Most cryptocurrencies were in the green Tuesday morning, extending their gains from a day earlier. Bitcoin was rising, while Ethereum was modestly lower. Market sentiment was boosted by several news such as major investment firm BlackRock and hedge fund billionaire Steven Cohen were entering the cryptocurrency market. Such moves mean more institutional money will flow into the nascent market. Read More
Today's Daily Dose brings you news about the resignation of Bellicum Pharma's CFO; Evolus' stock offering; Nevro's preliminary revenue figures for the second quarter of 2018 and full year outlook; FDA clearance of Quidel's new test and Spero's BARDA funding. Read More
Genentech, a member of the Roche Group (RHHBY), announced Tuesday that the Phase III CAPSTONE-2 study assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications from the flu met the study's primary objective. The study... Read More
blackrock-july17.jpg Asset-management giant BlackRock has set up a working group to look into the ways to take advantage of cryptocurrencies and their underlying technology blockchain, London's Financial News reported. The company is perhaps also exploring the possibilities of taking an active role in Bitcoin futures. BlackRock CEO Larry Fink, who earlier called bitcoin an index of money laundering, said, "We are ...
Read More
Follow RTT
Economic Calendar
07/17/18 16:0Net Long-term TIC FlowsMAY United States
07/17/18 16:0Total Net TIC FlowsMAY United States
07/17/18 10:0NAHB/Wells Fargo Housing Market IndexJUL United States
07/17/18 10:0CB Coincidence IndexJUN Brazil
07/17/18 10:0CB Leading IndexJUN Brazil
07/17/18 10:0Official Foreign ReservesJUL 13 Mexico
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
10/06/18AKCAInotersen (NDA)FDA decision on Tegsedi (Inotersen) for hereditary TTR amyloidosis (hATTR)
10/06/18IONSInotersen (NDA)FDA decision on Tegsedi (Inotersen) for hereditary TTR amyloidosis (hATTR)
10/05/18ACORINBRIJA (NDA)FDA decision on INBRIJA as a treatment for symptoms of OFF periods in people with Parkinson’s disease taking a carbidopa/levodopa regimen.
10/05/18VSTM Duvelisib (NDA)FDA decision on Duvelisib for relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
10/04/18RHHBYHEMLIBRA (sBLA)FDA decision on HEMLIBRA (emicizumab-kxwh) for hemophilia A without factor VIII inhibitors
View All